Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Joao A, Osso"'
Autor:
Amir R. Jalilian, Blanca Ocampo-García, Wanvimol Pasanphan, Tamer M. Sakr, Laura Melendez-Alafort, Mariano Grasselli, Ademar B. Lugao, Hassan Yousefnia, Clelia Dispenza, Siti Mohd Janib, Irfan U. Khan, Michał Maurin, Piotr Ulański, Say Chye Joachim Loo, Agnes Safrany, Joao A. Osso, Adriano Duatti, Kattesh V. Katti
Publikováno v:
Pharmaceutics, Vol 14, Iss 5, p 1060 (2022)
The rapidly growing interest in the application of nanoscience in the future design of radiopharmaceuticals and the development of nanosized radiopharmaceuticals in the late 2000′s, resulted in the creation of a Coordinated Research Project (CRP) b
Externí odkaz:
https://doaj.org/article/c7863d7a1cfe4d3d9cc2421b8a06412e
Autor:
G. Pupillo, Mohamed A. Gizawy, Amir Reza Jalilian, Aruna Korde, Cyrille Alliot, Sandor Takacs, Katherine Gagnon, Joao A. Osso, Jeong H. Park, Kotaro Nagatsu, Mayeen Uddin Khandaker, Aleksander Bilewicz, Suzanne E. Lapi, Sudipta Chakarborty, Subhani Okarvi, Mohammad R.A. Rovais, Valeriia N. Starovoitova, Renata Mikolajczak, Abdul Hamid Al Rayyes
Publikováno v:
Current Radiopharmaceuticals
Current Radiopharmaceuticals, 2021, 14 (4), pp.306-314. ⟨10.2174/1874471013999200928162322⟩
Current Radiopharmaceuticals, 2021, 14 (4), pp.306-314. ⟨10.2174/1874471013999200928162322⟩
Despite interesting properties, the use of 67Cu, 186Re and 47Sc theranostic radionuclides in preclinical studies and clinical trials is curtailed by their limited availability due to a lack of widely established production methods. An IAEA Coordinate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74984cfb7bda89f79342054631841c87
https://doi.org/10.2174/1874471013999200928162322
https://doi.org/10.2174/1874471013999200928162322
Autor:
Amir R. Jalilian, Arman Shahi, Ian P. Swainson, Hiroyuki Nakamura, Meera Venkatesh, Joao A. Osso
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 37(5)
Boron neutron capture therapy (BNCT) has been extant for decades and continues to be practiced in many centers around the globe. Most of the active clinical trials utilize boronophenylalanine as the drug containing boron atoms. The important aspect t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88798e542da815928743dfcd1667114a
https://pubmed.ncbi.nlm.nih.gov/35426728
https://pubmed.ncbi.nlm.nih.gov/35426728
Autor:
Marianne Patt, Yuji Kuge, Ulises Jáuregui-Haza, Zhi Yang, Jan Andersson, Ekoume Fany Pricile, Ephraim E. Parent, Ralph Santos-Oliveira, Johnny Vercouillie, Ya-Yao Huang, Joao A. Osso, Matthias M. Herth, Michelle L. James, Hank F. Kung, Eric D. Hostetler, Wolfgang Wadsak, Antony D. Gee, Rajiv Bhalla, Stephen Taylor, David W. Dick, Hua Zhu, Patrick J. Riss, Aruna Korde, Neil Vasdev, Yearn Seong Choe, Jae Min Jeong, Peter Scott, Suzanne E. Lapi
Publikováno v:
Gee, A D, Andersson, J, Bhalla, R, Choe, Y S, Dick, D W, Herth, M M, Hostetler, E D, Jauregui-Haza, U J, Huang, Y-Y, James, M L, Jeong, J M, Korde, A, Kuge, Y, Kung, H F, Lapi, S E, Osso, J A, Parent, E, Patt, M, Pricile, E F, Riss, P J, Santos-Oliveira, R, Taylor, S, Vasdev, N, Vercouillie, J, Wadsak, W, Yang, Z, Zhu, H & Scott, P J H 2020, ' Training the next generation of radiopharmaceutical scientists ', Nuclear Medicine and Biology, vol. 88-89, pp. 10-13 . https://doi.org/10.1016/j.nucmedbio.2020.06.004
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc3ae6d1a2d2a5c496964e068cb637a4
https://doi.org/10.1016/j.nucmedbio.2020.06.004
https://doi.org/10.1016/j.nucmedbio.2020.06.004
Publikováno v:
Current radiopharmaceuticals. 14(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6feb49882be2cd1eecc8232fd3d3eced
https://pubmed.ncbi.nlm.nih.gov/34784857
https://pubmed.ncbi.nlm.nih.gov/34784857
Autor:
Cornelia Hoehr, Hua Yang, Cathy S. Cutler, Randy Perron, Patrick Causey, Valery Radchenko, Kenneth R. Czerwinski, Samsonov Maxim, Thierry Stora, Ferrid Haddad, Paul Schaffer, Amir Reza Jalilian, D. Scott Wilbur, Olga Valzdorf, Yawen Li, Kirsten Leufgen, Kohshin Washiyama, Frank Bruchertseifer, Caterina F. Ramogida, Alfred Morgenstern, Charlotte Duchemin, Marek Pruszynski, Joao A. Osso, Haavar Gausemel
Publikováno v:
J Nucl Med
Encouraging results from targeted α-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review, we di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55396bbb82e1b71b92eedac45f2f47c
https://pubmed.ncbi.nlm.nih.gov/35772958
https://pubmed.ncbi.nlm.nih.gov/35772958
Publikováno v:
Journal of Nuclear Medicine JNUMED
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=r3c4b2081b22::a55396bbb82e1b71b92eedac45f2f47c
Autor:
Alessandra Boschi, Micol Pasquali, Joao A. Osso, Amir Reza Jalilian, Petra Martini, Arman Shahi
Publikováno v:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 64
Introduction The most common and aggressive primary malignancy of the central nervous system is Glioblastoma that, as a wide range of malignant solid tumor, is characterized by extensive hypoxic regions. A great number of PET radiopharmaceuticals hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37b6a23dedf9f2a2a37c1319645b158c
https://doi.org/10.23736/s1824-4785.20.03285-9
https://doi.org/10.23736/s1824-4785.20.03285-9
Autor:
Amir Reza Jalilian, Bianca Gutfilen, Fedor Zhuravlev, Matthew J. Harris, Behrouz Alirezapour, Jeff Smith, Brigitte Guérin, Thaer Assaad, Miguel A. Avila-Rodriguez, Irfan ullah Khan, Gert Luurtsema, Vijay Kumar, Ibrahim Aljammaz, Rubel Chakravarty, Hongyu Li, Adriano Duatti, Julia Vera-Araujo, Joao A. Osso
Publikováno v:
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of.... 64(4)
Copper-64 is a very attractive radioisotope with unique nuclear properties that allow using it as both a diagnostic and therapeutic agent, thus providing an almost ideal example of a theranostic radionuclide. A characteristic of Cu-64 stems from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32db45dbb323323431f36d4048c7a59b
https://pubmed.ncbi.nlm.nih.gov/33026211
https://pubmed.ncbi.nlm.nih.gov/33026211
Autor:
Amir R, Jalilian, Mohamed A, Gizawy, Cyrille, Alliot, Sandor, Takacs, Sudipta, Chakarborty, Mohammad R A, Rovais, Gaia, Pupillo, Kotaro, Nagatsu, Jeong H, Park, Mayeen Uddin, Khandaker, Renata, Mikolajczak, Aleksander, Bilewicz, Subhani, Okarvi, Katherine, Gagnon, Abdul H, Al Rayyes, Suzanne E, Lapi, Valeriia, Starovoitova, Aruna, Korde, Joao A, Osso
Publikováno v:
Current radiopharmaceuticals. 14(4)
Despite interesting properties, the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7b3dc04813b8af169bae5ea002a7d8be
https://pubmed.ncbi.nlm.nih.gov/32988359
https://pubmed.ncbi.nlm.nih.gov/32988359